{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:16:50Z","timestamp":1788898610910,"version":"build-2803163510"},"reference-count":201,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-025-02461-z","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T08:34:40Z","timestamp":1765442080000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Bridging the gap in Parkinson\u2019s disease research: from general pathophysiology to advanced 3d cell culture models"],"prefix":"10.1186","volume":"23","author":[{"given":"Buse","family":"Keles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baseerat","family":"Rumman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Abubaker Jassim Al","family":"Samarie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"G\u00fcrsoy \u00d6zdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zg\u00fcr","family":"\u00d6ztop Cakmak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6ktu\u011f","family":"Akyoldas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibel","family":"Ertan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emel","family":"Sokullu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"2461_CR1","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/MDS.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for parkinson\u2019s disease. Mov Disord. 2015;30:1591\u2013601. https:\/\/doi.org\/10.1002\/MDS.26424.","journal-title":"Mov Disord"},{"key":"2461_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2017.13","volume":"2017 3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, et al. Parkinson disease. Nat Reviews Disease Primers. 2017;2017 3:1. https:\/\/doi.org\/10.1038\/nrdp.2017.13.","journal-title":"Nat Reviews Disease Primers"},{"key":"2461_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/ng.3043","volume":"46","author":"MA Nalls","year":"2014","unstructured":"Nalls MA, Pankratz N, Lill CM, Do CB, Hernandez DG, Saad M, et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for parkinson\u2019s disease. Nat Genet 2014. 2014;46:9. https:\/\/doi.org\/10.1038\/ng.3043.","journal-title":"Nat Genet 2014"},{"key":"2461_CR4","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1212\/01.WNL.0000247740.47667.03\/SUPPL_FILE\/E1.DOC","volume":"68","author":"ER Dorsey","year":"2007","unstructured":"Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007;68:384\u20136. https:\/\/doi.org\/10.1212\/01.WNL.0000247740.47667.03\/SUPPL_FILE\/E1.DOC.","journal-title":"Neurology"},{"key":"2461_CR5","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/SCIENCE.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. Mutation in the \u03b1-Synuclein gene identified in families with parkinson\u2019s disease. Sci (1979). 1997;276:2045\u20137. https:\/\/doi.org\/10.1126\/SCIENCE.276.5321.2045.","journal-title":"Sci (1979)"},{"key":"2461_CR6","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1093\/BRAIN\/AWAA238","volume":"143","author":"J Horsager","year":"2020","unstructured":"Horsager J, Andersen KB, Knudsen K, Skj\u00e6rb\u00e6k C, Fedorova TD, Okkels N, et al. Brain-first versus body-first parkinson\u2019s disease: a multimodal imaging case-control study. Brain. 2020;143:3077\u201388. https:\/\/doi.org\/10.1093\/BRAIN\/AWAA238.","journal-title":"Brain"},{"key":"2461_CR7","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/S00702-016-1667-6","volume":"124","author":"N Titova","year":"2016","unstructured":"Titova N, Padmakumar C, Lewis SJG, Chaudhuri KR. Parkinson\u2019s: a syndrome rather than a disease? J Neural Transm. 2016;124:907. https:\/\/doi.org\/10.1007\/S00702-016-1667-6.","journal-title":"J Neural Transm"},{"key":"2461_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/B978-0-323-85538-9.00012-2","volume":"192","author":"Y Chu","year":"2023","unstructured":"Chu Y, Hirst WD, Kordower JH. Mixed pathology as a rule, not exception: time to reconsider disease nosology. Handb Clin Neurol. 2023;192:57\u201371. https:\/\/doi.org\/10.1016\/B978-0-323-85538-9.00012-2.","journal-title":"Handb Clin Neurol"},{"key":"2461_CR9","doi-asserted-by":"publisher","first-page":"173060","DOI":"10.1016\/J.PBB.2020.173060","volume":"199","author":"T Pingale","year":"2020","unstructured":"Pingale T, Gupta GL. Classic and evolving animal models in parkinson\u2019s disease. Pharmacol Biochem Behav. 2020;199:173060. https:\/\/doi.org\/10.1016\/J.PBB.2020.173060.","journal-title":"Pharmacol Biochem Behav"},{"key":"2461_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3390\/BIOENGINEERING10010093","volume":"10","author":"A Louit","year":"2023","unstructured":"Louit A, Galbraith T, Berthod F. Vitro 3D modeling of neurodegenerative Diseases. Bioengineering 2023. Page 93. 2023;10:10:93. https:\/\/doi.org\/10.3390\/BIOENGINEERING10010093.","journal-title":"Page 93"},{"key":"2461_CR11","doi-asserted-by":"publisher","unstructured":"Habanjar O, Diab-Assaf M, Caldefie-Chezet F, Delort L. 3D cell culture systems: tumor Application, Advantages, and disadvantages. Int J Mol Sci. 2021;22. https:\/\/doi.org\/10.3390\/IJMS222212200.","DOI":"10.3390\/IJMS222212200"},{"key":"2461_CR12","doi-asserted-by":"publisher","first-page":"1800927","DOI":"10.1002\/ADVS.201800927","volume":"6","author":"S Bolognin","year":"2018","unstructured":"Bolognin S, Foss\u00e9pr\u00e9 M, Qing X, Jarazo J, \u0160\u010dan\u010dar J, Moreno EL, et al. 3D cultures of parkinson\u2019s Disease-Specific dopaminergic neurons for high content phenotyping and drug testing. Adv Sci. 2018;6:1800927. https:\/\/doi.org\/10.1002\/ADVS.201800927.","journal-title":"Adv Sci"},{"key":"2461_CR13","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","volume":"20","author":"H Bernheimer","year":"1973","unstructured":"Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F. Brain dopamine and the syndromes of Parkinson and huntington Clinical, morphological and neurochemical correlations. J Neurol Sci. 1973;20:415\u201355. https:\/\/doi.org\/10.1016\/0022-510X(73)90175-5.","journal-title":"J Neurol Sci"},{"key":"2461_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4103\/1673-5374.343895","volume":"18","author":"A Cardinale","year":"2022","unstructured":"Cardinale A, Calabrese V. The intricate debate on neurodegeneration and neuroinflammation in parkinson\u2019s disease: which came first? Neural Regen Res. 2022;18:125. https:\/\/doi.org\/10.4103\/1673-5374.343895.","journal-title":"Neural Regen Res"},{"key":"2461_CR15","doi-asserted-by":"publisher","unstructured":"Ju\u00e1rez Olgu\u00edn H, Calder\u00f3n Guzm\u00e1n D, Hern\u00e1ndez Garc\u00eda E, Barrag\u00e1n Mej\u00eda G. The role of dopamine and its dysfunction as a consequence of oxidative stress. Oxid Med Cell Longev. 2016;2016. https:\/\/doi.org\/10.1155\/2016\/9730467.","DOI":"10.1155\/2016\/9730467"},{"key":"2461_CR16","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/J.NEURON.2013.09.004","volume":"79","author":"JT Bendor","year":"2013","unstructured":"Bendor JT, Logan TP, Edwards RH. The function of \u03b1-synuclein. Neuron. 2013;79:1044\u201366. https:\/\/doi.org\/10.1016\/J.NEURON.2013.09.004.","journal-title":"Neuron"},{"key":"2461_CR17","doi-asserted-by":"publisher","first-page":"6645","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VMY, Trojanowski JQ, Jakes R, Goedert M. \u03b1-Synuclein in lewy bodies. Nat 1997. 1997;388:6645. https:\/\/doi.org\/10.1038\/42166.","journal-title":"Nat 1997"},{"key":"2461_CR18","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2\/ASSET\/91B19D08-23D5-4D50-B57A-065F464C1052\/MAIN.ASSETS\/GR3.JPG","volume":"403","author":"HR Morris","year":"2024","unstructured":"Morris HR, Spillantini MG, Sue CM, Williams-Gray CH. The pathogenesis of parkinson\u2019s disease. Lancet. 2024;403:293\u2013304. https:\/\/doi.org\/10.1016\/S0140-6736(23)01478-2\/ASSET\/91B19D08-23D5-4D50-B57A-065F464C1052\/MAIN.ASSETS\/GR3.JPG.","journal-title":"Lancet"},{"key":"2461_CR19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, De Vos RAI, Jansen Steur ENH, Braak E. Staging of brain pathology related to sporadic parkinson\u2019s disease. Neurobiol Aging. 2003;24:197\u2013211. https:\/\/doi.org\/10.1016\/S0197-4580(02)00065-9.","journal-title":"Neurobiol Aging"},{"key":"2461_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41419-019-2091-2","volume":"10","author":"GK Ganjam","year":"2019","unstructured":"Ganjam GK, Bolte K, Matschke LA, Neitemeier S, Dolga AM, H\u00f6llerhage M, et al. Mitochondrial damage by \u03b1-synuclein causes cell death in human dopaminergic neurons. Cell Death Disease 2019. 2019;10:11. https:\/\/doi.org\/10.1038\/s41419-019-2091-2.","journal-title":"Cell Death Disease 2019"},{"key":"2461_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/ncb3177","volume":"17","author":"H Cha-Molstad","year":"2015","unstructured":"Cha-Molstad H, Sung KS, Hwang J, Kim KA, Yu JE, Yoo YD, et al. Amino-terminal arginylation targets Endoplasmic reticulum chaperone bip for autophagy through p62 binding. Nat Cell Biology 2014. 2015;17:7. https:\/\/doi.org\/10.1038\/ncb3177.","journal-title":"Nat Cell Biology 2014"},{"key":"2461_CR22","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1007\/S11064-020-03126-8\/METRICS","volume":"45","author":"AC Nascimento","year":"2020","unstructured":"Nascimento AC, Erustes AG, Reckziegel P, Bincoletto C, Ureshino RP, Pereira GJS, et al. \u03b1-Synuclein overexpression induces lysosomal dysfunction and autophagy impairment in human neuroblastoma SH-SY5Y. Neurochem Res. 2020;45:2749\u201361. https:\/\/doi.org\/10.1007\/S11064-020-03126-8\/METRICS.","journal-title":"Neurochem Res"},{"key":"2461_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S40478-020-0894-0\/FIGURES\/7","volume":"8","author":"C McKinnon","year":"2020","unstructured":"McKinnon C, De Snoo ML, Gondard E, Neudorfer C, Chau H, Ngana SG, et al. Early-onset impairment of the ubiquitin-proteasome system in dopaminergic neurons caused by \u03b1-synuclein. Acta Neuropathol Commun. 2020;8:1\u201316. https:\/\/doi.org\/10.1186\/S40478-020-0894-0\/FIGURES\/7.","journal-title":"Acta Neuropathol Commun"},{"key":"2461_CR24","doi-asserted-by":"publisher","unstructured":"Marques O, Outeiro TF. Alpha-synuclein: from secretion to dysfunction and death. Cell Death Dis. 2012;3. https:\/\/doi.org\/10.1038\/CDDIS.2012.94.","DOI":"10.1038\/CDDIS.2012.94"},{"key":"2461_CR25","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/J.BBR.2017.06.047","volume":"333","author":"JTS Fortuna","year":"2017","unstructured":"Fortuna JTS, Gralle M, Beckman D, Neves FS, Diniz LP, Frost PS, et al. Brain infusion of \u03b1-synuclein oligomers induces motor and non-motor parkinson\u2019s disease-like symptoms in mice. Behav Brain Res. 2017;333:150\u201360. https:\/\/doi.org\/10.1016\/J.BBR.2017.06.047.","journal-title":"Behav Brain Res"},{"key":"2461_CR26","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1126\/SCIENCE.AAN6160","volume":"358","author":"G Fusco","year":"2017","unstructured":"Fusco G, Chen SW, Williamson PTF, Cascella R, Perni M, Jarvis JA, et al. Structural basis of membrane disruption and cellular toxicity by \u03b1-synuclein oligomers. Science. 2017;358:1440\u20133. https:\/\/doi.org\/10.1126\/SCIENCE.AAN6160.","journal-title":"Science"},{"key":"2461_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/J.NEUINT.2018.01.006","volume":"114","author":"W Wang","year":"2018","unstructured":"Wang W, Song N, Jia F, Tang T, Bao W, Zuo C, et al. Genomic DNA levels of mutant alpha-synuclein correlate with non-motor symptoms in an A53T parkinson\u2019s disease mouse model. Neurochem Int. 2018;114:71\u20139. https:\/\/doi.org\/10.1016\/J.NEUINT.2018.01.006.","journal-title":"Neurochem Int"},{"key":"2461_CR28","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1523\/JNEUROSCI.0089-14.2015","volume":"35","author":"L Chen","year":"2015","unstructured":"Chen L, Xie Z, Turkson S, Zhuang X. A53T human \u03b1-synuclein overexpression in Transgenic mice induces pervasive mitochondria macroautophagy defects preceding dopamine neuron degeneration. J Neurosci. 2015;35:890\u2013905. https:\/\/doi.org\/10.1523\/JNEUROSCI.0089-14.2015.","journal-title":"J Neurosci"},{"key":"2461_CR29","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/S00221-016-4836-9","volume":"235","author":"TQ Melo","year":"2017","unstructured":"Melo TQ, van Zomeren KC, Ferrari MFR, Boddeke HWGM, Copray JCVM. Impairment of mitochondria dynamics by human A53T \u03b1-synuclein and rescue by NAP (davunetide) in a cell model for parkinson\u2019s disease. Exp Brain Res. 2017;235:731\u201342. https:\/\/doi.org\/10.1007\/S00221-016-4836-9.","journal-title":"Exp Brain Res"},{"key":"2461_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-54034-z","volume":"9","author":"T Kilpel\u00e4inen","year":"2019","unstructured":"Kilpel\u00e4inen T, Julku UH, Svarcbahs R, My\u00f6h\u00e4nen TT. Behavioural and dopaminergic changes in double mutated human A30P*A53T alpha-synuclein Transgenic mouse model of Parkinson\u00b4s disease. Sci Rep 2019. 2019;9:1. https:\/\/doi.org\/10.1038\/s41598-019-54034-z.","journal-title":"Sci Rep 2019"},{"key":"2461_CR31","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1523\/JNEUROSCI.5699-09.2010","volume":"30","author":"E Emmanouilidou","year":"2010","unstructured":"Emmanouilidou E, Melachroinou K, Roumeliotis T, Garbis SD, Ntzouni M, Margaritis LH, et al. Cell-Produced \u03b1-Synuclein is secreted in a Calcium-Dependent manner by exosomes and impacts neuronal survival. J Neurosci. 2010;30:6838. https:\/\/doi.org\/10.1523\/JNEUROSCI.5699-09.2010.","journal-title":"J Neurosci"},{"key":"2461_CR32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3233\/JPD-2011-11004","volume":"1","author":"Z Kurowska","year":"2011","unstructured":"Kurowska Z, Englund E, Widner H, Lindvall O, Li JY, Brundin P. Signs of degeneration in 12-22-year old grafts of mesencephalic dopamine neurons in patients with parkinson\u2019s disease. J Parkinsons Dis. 2011;1:83\u201392. https:\/\/doi.org\/10.3233\/JPD-2011-11004.","journal-title":"J Parkinsons Dis"},{"key":"2461_CR33","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1093\/BRAIN\/AWX255","volume":"140","author":"G Cisbani","year":"2017","unstructured":"Cisbani G, Maxan A, Kordower JH, Planel E, Freeman TB, Cicchetti F. Presence of Tau pathology within foetal neural allografts in patients with huntington\u2019s and parkinson\u2019s disease. Brain. 2017;140:2982. https:\/\/doi.org\/10.1093\/BRAIN\/AWX255.","journal-title":"Brain"},{"key":"2461_CR34","doi-asserted-by":"publisher","first-page":"651","DOI":"10.2147\/NDT.S235562","volume":"16","author":"S Hu","year":"2020","unstructured":"Hu S, Hu M, Liu J, Zhang B, Zhang Z, Zhou FH, et al. Phosphorylation of Tau and \u03b1-Synuclein induced neurodegeneration in MPTP mouse model of parkinson\u2019s disease. Neuropsychiatr Dis Treat. 2020;16:651. https:\/\/doi.org\/10.2147\/NDT.S235562.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2461_CR35","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1126\/SCIENCE.1082324\/SUPPL_FILE\/GIASSONSOM.PDF","volume":"300","author":"BI Giasson","year":"2003","unstructured":"Giasson BI, Forman MS, Higuchi M, Golbe LI, Graves CL, Kotzbauer PT, et al. Initiation and synergistic fibrillization of Tau and alpha-synuctein. Sci (1979). 2003;300:636\u201340. https:\/\/doi.org\/10.1126\/SCIENCE.1082324\/SUPPL_FILE\/GIASSONSOM.PDF.","journal-title":"Sci (1979)"},{"key":"2461_CR36","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0490-10.2010","volume":"30","author":"LK Clinton","year":"2010","unstructured":"Clinton LK, Blurton-Jones M, Myczek K, Trojanowski JQ, LaFerla FM. Synergistic interactions between A\u03b2, Tau, and \u03b1-Synuclein: acceleration of neuropathology and cognitive decline. J Neurosci. 2010;30:7281. https:\/\/doi.org\/10.1523\/JNEUROSCI.0490-10.2010.","journal-title":"J Neurosci"},{"key":"2461_CR37","doi-asserted-by":"publisher","first-page":"7470","DOI":"10.1074\/JBC.RA119.012284","volume":"295","author":"J Lu","year":"2020","unstructured":"Lu J, Zhang S, Ma X, Jia C, Liu Z, Huang C, et al. Structural basis of the interplay between \u03b1-synuclein and Tau in regulating pathological amyloid aggregation. J Biol Chem. 2020;295:7470\u201380. https:\/\/doi.org\/10.1074\/JBC.RA119.012284.","journal-title":"J Biol Chem"},{"key":"2461_CR38","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1002\/JNR.25101","volume":"100","author":"K Amrutha","year":"2022","unstructured":"Amrutha K, Mishra A, Singh S. Implications of intracellular protein degradation pathways in parkinson\u2019s disease and therapeutics. J Neurosci Res. 2022;100:1834\u201344. https:\/\/doi.org\/10.1002\/JNR.25101.","journal-title":"J Neurosci Res"},{"key":"2461_CR39","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1007\/S12035-022-02851-1","volume":"59","author":"T Behl","year":"2022","unstructured":"Behl T, Kumar S, Althafar ZM, Sehgal A, Singh S, Sharma N, et al. Exploring the role of Ubiquitin-Proteasome system in parkinson\u2019s disease. Mol Neurobiol. 2022;59:4257\u201373. https:\/\/doi.org\/10.1007\/S12035-022-02851-1.","journal-title":"Mol Neurobiol"},{"key":"2461_CR40","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/ANA.20186","volume":"56","author":"KSP McNaught","year":"2004","unstructured":"McNaught KSP, Perl DP, Brownell AL, Olanow CW. Systemic exposure to proteasome inhibitors causes a progressive model of parkinson\u2019s disease. Ann Neurol. 2004;56:149\u201362. https:\/\/doi.org\/10.1002\/ANA.20186.","journal-title":"Ann Neurol"},{"key":"2461_CR41","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.4161\/AUTO.21011","volume":"8","author":"B Dehay","year":"2012","unstructured":"Dehay B, Martinez-Vicente M, Ramirez A, Perier C, Klein C, Vila M, et al. Lysosomal dysfunction in Parkinson disease: ATP13A2 gets into the groove. Autophagy. 2012;8:1389\u201391. https:\/\/doi.org\/10.4161\/AUTO.21011.","journal-title":"Autophagy"},{"key":"2461_CR42","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/NG1884","volume":"38","author":"A Ramirez","year":"2006","unstructured":"Ramirez A, Heimbach A, Gr\u00fcndemann J, Stiller B, Hampshire D, Cid LP, et al. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet. 2006;38:1184\u201391. https:\/\/doi.org\/10.1038\/NG1884.","journal-title":"Nat Genet"},{"key":"2461_CR43","doi-asserted-by":"publisher","unstructured":"Maiti P, Manna J, Dunbar GL, Maiti P, Dunbar GL. Current Understanding of the molecular mechanisms in parkinson\u2019s disease: targets for potential treatments. Transl Neurodegener 2017;6. https:\/\/doi.org\/10.1186\/S40035-017-0099-Z","DOI":"10.1186\/S40035-017-0099-Z"},{"key":"2461_CR44","doi-asserted-by":"publisher","first-page":"493603","DOI":"10.3389\/FNINS.2019.01124\/BIBTEX","volume":"13","author":"C Jia","year":"2019","unstructured":"Jia C, Ma X, Liu Z, Gu J, Zhang X, Li D, et al. Different heat shock proteins bind \u03b1-Synuclein with distinct mechanisms and synergistically prevent its amyloid aggregation. Front Neurosci. 2019;13:493603. https:\/\/doi.org\/10.3389\/FNINS.2019.01124\/BIBTEX.","journal-title":"Front Neurosci"},{"key":"2461_CR45","doi-asserted-by":"publisher","first-page":"7788","DOI":"10.1038\/s41586-019-1808-9","volume":"577","author":"BM Burmann","year":"2019","unstructured":"Burmann BM, Gerez JA, Mate\u010dko-Burmann I, Campioni S, Kumari P, Ghosh D, et al. Regulation of \u03b1-synuclein by chaperones in mammalian cells. Nat 2019. 2019;577:7788. https:\/\/doi.org\/10.1038\/s41586-019-1808-9.","journal-title":"Nat 2019"},{"key":"2461_CR46","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/CNS.12200","volume":"20","author":"TC Moloney","year":"2014","unstructured":"Moloney TC, Hyland R, O\u2019Toole D, Paucard A, Kirik D, O\u2019Doherty A, et al. Heat shock protein 70 reduces \u03b1-synuclein-induced predegenerative neuronal dystrophy in the \u03b1-synuclein viral gene transfer rat model of parkinson\u2019s disease. CNS Neurosci Ther. 2014;20:50\u20138. https:\/\/doi.org\/10.1111\/CNS.12200.","journal-title":"CNS Neurosci Ther"},{"key":"2461_CR47","doi-asserted-by":"publisher","first-page":"4614","DOI":"10.1016\/J.JMB.2013.08.006","volume":"425","author":"S Daturpalli","year":"2013","unstructured":"Daturpalli S, Waudby CA, Meehan S, Jackson SE. Hsp90 inhibits \u03b1-synuclein aggregation by interacting with soluble oligomers. J Mol Biol. 2013;425:4614\u201328. https:\/\/doi.org\/10.1016\/J.JMB.2013.08.006.","journal-title":"J Mol Biol"},{"key":"2461_CR48","doi-asserted-by":"publisher","first-page":"10154","DOI":"10.1523\/JNEUROSCI.5311-12.2013","volume":"33","author":"DI Dryanovski","year":"2013","unstructured":"Dryanovski DI, Guzman JN, Xie Z, Galteri DJ, Volpicelli-Daley LA, Lee VMY, et al. Calcium entry and \u03b1-Synuclein inclusions elevate dendritic mitochondrial oxidant stress in dopaminergic neurons. J Neurosci. 2013;33:10154\u201364. https:\/\/doi.org\/10.1523\/JNEUROSCI.5311-12.2013.","journal-title":"J Neurosci"},{"key":"2461_CR49","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/S40478-017-0416-X","volume":"5","author":"CW Ip","year":"2017","unstructured":"Ip CW, Klaus LC, Karikari AA, Visanji NP, Brotchie JM, Lang AE, et al. AAV1\/2-induced overexpression of A53T-\u03b1-synuclein in the substantia Nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for parkinson\u2019s disease. Acta Neuropathol Commun. 2017;5:11. https:\/\/doi.org\/10.1186\/S40478-017-0416-X.","journal-title":"Acta Neuropathol Commun"},{"key":"2461_CR50","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3233\/JPD-2011-11023","volume":"1","author":"GE Meredith","year":"2011","unstructured":"Meredith GE, Rademacher DJ. MPTP mouse models of parkinson\u2019s disease: an update. J Parkinsons Dis. 2011;1:19. https:\/\/doi.org\/10.3233\/JPD-2011-11023.","journal-title":"J Parkinsons Dis"},{"key":"2461_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0006-8993(95)01255-9","volume":"715","author":"VG Desai","year":"1996","unstructured":"Desai VG, Feuers RJ, Hart RW, Ali SF. MPP+-induced neurotoxicity in mouse is age-dependent: evidenced by the selective Inhibition of complexes of electron transport. Brain Res. 1996;715:1\u20138. https:\/\/doi.org\/10.1016\/0006-8993(95)01255-9.","journal-title":"Brain Res"},{"key":"2461_CR52","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/J.BBRC.2020.02.170","volume":"525","author":"X Jiang shun","year":"2020","unstructured":"Jiang shun X, Chen X, mei, Hua W, He ling J, Liu T, Li jia X, et al. PINK1\/Parkin mediated mitophagy ameliorates palmitic acid-induced apoptosis through reducing mitochondrial ROS production in podocytes. Biochem Biophys Res Commun. 2020;525:954\u201361. https:\/\/doi.org\/10.1016\/J.BBRC.2020.02.170.","journal-title":"Biochem Biophys Res Commun"},{"key":"2461_CR53","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1083\/JCB.200809125","volume":"183","author":"D Narendra","year":"2008","unstructured":"Narendra D, Tanaka A, Suen DF, Youle RJ. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol. 2008;183:795\u2013803. https:\/\/doi.org\/10.1083\/JCB.200809125.","journal-title":"J Cell Biol"},{"key":"2461_CR54","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1126\/SCIENCE.1096284","volume":"304","author":"EM Valente","year":"2004","unstructured":"Valente EM, Abou-Sleiman PM, Caputo V, Muqit MMK, Harvey K, Gispert S, et al. Hereditary early-onset parkinson\u2019s disease caused by mutations in PINK1. Sci (1979). 2004;304:1158\u201360. https:\/\/doi.org\/10.1126\/SCIENCE.1096284.","journal-title":"Sci (1979)"},{"key":"2461_CR55","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1073\/PNAS.0737556100\/ASSET\/91C3AEE2-BD96-465F-9233-81F19B4ACDE9\/ASSETS\/GRAPHIC\/PQ0737556006.JPEG","volume":"100","author":"JC Greene","year":"2003","unstructured":"Greene JC, Whitworth AJ, Kuo I, Andrews LA, Feany MB, Pallanck LJ. Mitochondrial pathology and apoptotic muscle degeneration in drosophila parkin mutants. Proc Natl Acad Sci U S A. 2003;100:4078\u201383. https:\/\/doi.org\/10.1073\/PNAS.0737556100\/ASSET\/91C3AEE2-BD96-465F-9233-81F19B4ACDE9\/ASSETS\/GRAPHIC\/PQ0737556006.JPEG.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2461_CR56","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/S41586-019-1405-Y","volume":"571","author":"D Matheoud","year":"2019","unstructured":"Matheoud D, Cannon T, Voisin A, Penttinen AM, Ramet L, Fahmy AM, et al. Intestinal infection triggers parkinson\u2019s disease-like symptoms in Pink1-\/- mice. Nature. 2019;571:565\u20139. https:\/\/doi.org\/10.1038\/S41586-019-1405-Y.","journal-title":"Nature"},{"key":"2461_CR57","doi-asserted-by":"publisher","unstructured":"Day JO, Mullin S. The genetics of parkinson\u2019s disease and implications for clinical practice. Genes (Basel). 2021;12. https:\/\/doi.org\/10.3390\/GENES12071006.","DOI":"10.3390\/GENES12071006"},{"key":"2461_CR58","doi-asserted-by":"publisher","first-page":"425800","DOI":"10.3389\/FNANA.2018.00113\/BIBTEX","volume":"12","author":"NLG Del Rey","year":"2018","unstructured":"Del Rey NLG, Quiroga-Varela A, Garbayo E, Carballo-Carbajal I, Fern\u00e1ndez-Santiago R, Monje MHG, et al. Advances in parkinson\u2019s disease: 200 years later. Front Neuroanat. 2018;12:425800. https:\/\/doi.org\/10.3389\/FNANA.2018.00113\/BIBTEX.","journal-title":"Front Neuroanat"},{"key":"2461_CR59","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/WCO.0000000000001167","volume":"36","author":"A Cherian","year":"2023","unstructured":"Cherian A, Divya KP, Vijayaraghavan A. Parkinson\u2019s disease - genetic cause. Curr Opin Neurol. 2023;36:292\u2013301. https:\/\/doi.org\/10.1097\/WCO.0000000000001167.","journal-title":"Curr Opin Neurol"},{"key":"2461_CR60","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1016\/J.NEUROBIOLAGING.2014.04.032","volume":"35","author":"M Oliveras-Salv\u00e1","year":"2014","unstructured":"Oliveras-Salv\u00e1 M, Macchi F, Coessens V, Deleersnijder A, G\u00e9rard M, Van der Perren A, et al. Alpha-synuclein-induced neurodegeneration is exacerbated in PINK1 knockout mice. Neurobiol Aging. 2014;35:2625\u201336. https:\/\/doi.org\/10.1016\/J.NEUROBIOLAGING.2014.04.032.","journal-title":"Neurobiol Aging"},{"key":"2461_CR61","doi-asserted-by":"publisher","unstructured":"Klein C, Westenberger A. Genetics of parkinson\u2019s disease. Cold Spring Harb Perspect Med. 2012;2. https:\/\/doi.org\/10.1101\/CSHPERSPECT.A008888.","DOI":"10.1101\/CSHPERSPECT.A008888"},{"key":"2461_CR62","doi-asserted-by":"publisher","unstructured":"Ma KY, Fokkens MR, Reggiori F, Mari M, Verbeek DS. Parkinson\u2019s disease-associated VPS35 mutant reduces mitochondrial membrane potential and impairs PINK1\/Parkin-mediated mitophagy. Transl Neurodegener. 2021;10. https:\/\/doi.org\/10.1186\/S40035-021-00243-4.","DOI":"10.1186\/S40035-021-00243-4"},{"key":"2461_CR63","doi-asserted-by":"publisher","first-page":"631145","DOI":"10.3389\/FNEUR.2021.631145\/BIBTEX","volume":"12","author":"JA Tunold","year":"2021","unstructured":"Tunold JA, Geut H, Rozemuller JMA, Henriksen SP, Toft M, van de Berg WDJ, et al. APOE and MAPT are associated with dementia in neuropathologically confirmed parkinson\u2019s disease. Front Neurol. 2021;12:631145. https:\/\/doi.org\/10.3389\/FNEUR.2021.631145\/BIBTEX.","journal-title":"Front Neurol"},{"key":"2461_CR64","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1126\/SCIENCE.274.5290.1197","volume":"274","author":"MH Polymeropoulos","year":"1996","unstructured":"Polymeropoulos MH, Higgins JJ, Golbe LI, Johnson WG, Ide SE, Di Iorio G, et al. Mapping of a gene for parkinson\u2019s disease to chromosome 4q21-q23. Science. 1996;274:1197\u20139. https:\/\/doi.org\/10.1126\/SCIENCE.274.5290.1197.","journal-title":"Science"},{"key":"2461_CR65","doi-asserted-by":"publisher","unstructured":"Goedert M. The awakening of \u03b1-synuclein. Nature. 1997 388:6639 1997;388:232\u20133. https:\/\/doi.org\/10.1038\/40767","DOI":"10.1038\/40767"},{"key":"2461_CR66","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/ANA.10846","volume":"55","author":"M Farrer","year":"2004","unstructured":"Farrer M, Kachergus J, Forno L, Lincoln S, Wang DS, Hulihan M, et al. Comparison of kindreds with parkinsonism and \u03b1-synuclein genomic multiplications. Ann Neurol. 2004;55:174\u20139. https:\/\/doi.org\/10.1002\/ANA.10846.","journal-title":"Ann Neurol"},{"key":"2461_CR67","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/S0140-6736(04)17104-3","volume":"364","author":"P Ib\u00e1\u00f1ez","year":"2004","unstructured":"Ib\u00e1\u00f1ez P, Bonnet AM, D\u00e9barges B, Lohmann E, Tison F, Pollak P, et al. Causal relation between \u03b1-synuclein gene duplication and Familial parkinson\u2019s disease. Lancet. 2004;364:1169\u201371. https:\/\/doi.org\/10.1016\/S0140-6736(04)17104-3.","journal-title":"Lancet"},{"key":"2461_CR68","doi-asserted-by":"publisher","first-page":"fcab223","DOI":"10.1093\/BRAINCOMMS\/FCAB223","volume":"3","author":"NV Mohamed","year":"2021","unstructured":"Mohamed NV, Sirois J, Ramamurthy J, Mathur M, L\u00e9pine P, Deneault E, et al. Midbrain organoids with an SNCA gene triplication model key features of synucleinopathy. Brain Commun. 2021;3:fcab223. https:\/\/doi.org\/10.1093\/BRAINCOMMS\/FCAB223.","journal-title":"Brain Commun"},{"key":"2461_CR69","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1093\/HMG\/DDAA183","volume":"29","author":"V Chen","year":"2020","unstructured":"Chen V, Moncalvo M, Tringali D, Tagliafierro L, Shriskanda A, Ilich E, et al. The mechanistic role of alpha-synuclein in the nucleus: impaired nuclear function caused by Familial parkinson\u2019s disease SNCA mutations. Hum Mol Genet. 2020;29:3107\u201321. https:\/\/doi.org\/10.1093\/HMG\/DDAA183.","journal-title":"Hum Mol Genet"},{"key":"2461_CR70","doi-asserted-by":"publisher","unstructured":"Regensburger M, Stemick J, Masliah E, Kohl Z, Winner B. Intracellular A53T mutant \u03b1-Synuclein impairs adult hippocampal newborn neuron integration. Front Cell Dev Biol. 2020;8. https:\/\/doi.org\/10.3389\/FCELL.2020.561963.","DOI":"10.3389\/FCELL.2020.561963"},{"key":"2461_CR71","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/J.NEUROBIOLAGING.2021.05.012","volume":"106","author":"RC Gentzel","year":"2021","unstructured":"Gentzel RC, Toolan D, Jinn S, Schachter JB, Ma L, Kahle PJ, et al. Intracranial administration of alpha-synuclein fibrils in A30P-synuclein Transgenic mice causes robust synucleinopathy and microglial induction. Neurobiol Aging. 2021;106:12\u201325. https:\/\/doi.org\/10.1016\/J.NEUROBIOLAGING.2021.05.012.","journal-title":"Neurobiol Aging"},{"key":"2461_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-16386-3","volume":"11","author":"K Zhao","year":"2020","unstructured":"Zhao K, Li Y, Liu Z, Long H, Zhao C, Luo F, et al. Parkinson\u2019s disease associated mutation E46K of \u03b1-synuclein triggers the formation of a distinct fibril structure. Nat Commun 2020. 2020;11:1. https:\/\/doi.org\/10.1038\/s41467-020-16386-3.","journal-title":"Nat Commun 2020"},{"key":"2461_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.NEUROSCIENCE.2019.01.006","volume":"401","author":"AA Rahman","year":"2019","unstructured":"Rahman AA, Morrison BE. Contributions of VPS35 mutations to parkinson\u2019s disease. Neuroscience. 2019;401:1\u201310. https:\/\/doi.org\/10.1016\/J.NEUROSCIENCE.2019.01.006.","journal-title":"Neuroscience"},{"key":"2461_CR74","doi-asserted-by":"publisher","first-page":"4621","DOI":"10.1093\/HMG\/DDU178","volume":"23","author":"E Tsika","year":"2014","unstructured":"Tsika E, Glauser L, Moser R, Fiser A, Daniel G, Sheerin UM, et al. Parkinson\u2019s disease-linked mutations in VPS35 induce dopaminergic neurodegeneration. Hum Mol Genet. 2014;23:4621\u201338. https:\/\/doi.org\/10.1093\/HMG\/DDU178.","journal-title":"Hum Mol Genet"},{"key":"2461_CR75","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/J.BBRC.2016.11.088","volume":"482","author":"H Vakifahmetoglu-Norberg","year":"2017","unstructured":"Vakifahmetoglu-Norberg H, Ouchida AT, Norberg E. The role of mitochondria in metabolism and cell death. Biochem Biophys Res Commun. 2017;482:426\u201331. https:\/\/doi.org\/10.1016\/J.BBRC.2016.11.088.","journal-title":"Biochem Biophys Res Commun"},{"key":"2461_CR76","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/S0140-6736(05)60746-5","volume":"352","author":"CB L\u00fccking","year":"1998","unstructured":"L\u00fccking CB, Abbas N, D\u00fcrr A, Bonifati V, Bonnet AM, De Broucker T, et al. Homozygous deletions in parkin gene in European and North African families with autosomal recessive juvenile parkinsonism. Lancet. 1998;352:1355\u20136. https:\/\/doi.org\/10.1016\/S0140-6736(05)60746-5.","journal-title":"Lancet"},{"key":"2461_CR77","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/S004390050845\/METRICS","volume":"103","author":"E Leroy","year":"1998","unstructured":"Leroy E, Anastasopoulos D, Konitsiotis S, Lavedan C, Polymeropoulos MH. Deletions in the parkin gene and genetic heterogeneity in a Greek family with early onset parkinson\u2019s disease. Hum Genet. 1998;103:424\u20137. https:\/\/doi.org\/10.1007\/S004390050845\/METRICS.","journal-title":"Hum Genet"},{"key":"2461_CR78","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1006\/BBRC.1998.9134","volume":"249","author":"N Hattori","year":"1998","unstructured":"Hattori N, Matsumine H, Asakawa S, Kitada T, Yoshino H, Elibol B, et al. Point mutations (Thr240Arg and Ala311Stop) in TheParkinGene. Biochem Biophys Res Commun. 1998;249:754\u20138. https:\/\/doi.org\/10.1006\/BBRC.1998.9134.","journal-title":"Biochem Biophys Res Commun"},{"key":"2461_CR79","doi-asserted-by":"publisher","first-page":"18614","DOI":"10.1074\/JBC.M401135200","volume":"279","author":"JJ Palacino","year":"2004","unstructured":"Palacino JJ, Sagi D, Goldberg MS, Krauss S, Motz C, Wacker M, et al. Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J Biol Chem. 2004;279:18614\u201322. https:\/\/doi.org\/10.1074\/JBC.M401135200.","journal-title":"J Biol Chem"},{"key":"2461_CR80","doi-asserted-by":"publisher","first-page":"s117","DOI":"10.1007\/S100720200097\/METRICS","volume":"23","author":"EM Valente","year":"2002","unstructured":"Valente EM, Brancati F, Caputo V, Graham EA, Davis MB, Ferraris A, et al. PARK6 is a common cause of Familial parkinsonism. Neurol Sci. 2002;23:s117\u20138. https:\/\/doi.org\/10.1007\/S100720200097\/METRICS.","journal-title":"Neurol Sci"},{"key":"2461_CR81","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/MDS.10034","volume":"16","author":"AR Bentivoglio","year":"2001","unstructured":"Bentivoglio AR, Cortelli P, Valente EM, Ialongo T, Ferraris A, Elia A, et al. Phenotypic characterisation of autosomal recessive PARK6-linked parkinsonism in three unrelated Italian families. Mov Disord. 2001;16:999\u20131006. https:\/\/doi.org\/10.1002\/MDS.10034.","journal-title":"Mov Disord"},{"key":"2461_CR82","doi-asserted-by":"publisher","first-page":"e3056","DOI":"10.1038\/CDDIS.2017.427","volume":"8","author":"J Liu","year":"2017","unstructured":"Liu J, Wang X, Lu Y, Duan C, Gao G, Lu L, et al. Pink1 interacts with \u03b1-synuclein and abrogates \u03b1-synuclein-induced neurotoxicity by activating autophagy. Cell Death Dis. 2017;8:e3056. https:\/\/doi.org\/10.1038\/CDDIS.2017.427.","journal-title":"Cell Death Dis"},{"key":"2461_CR83","doi-asserted-by":"publisher","first-page":"11364","DOI":"10.1073\/PNAS.0802076105","volume":"105","author":"CA Gautier","year":"2008","unstructured":"Gautier CA, Kitada T, Shen J. Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress. Proc Natl Acad Sci U S A. 2008;105:11364\u20139. https:\/\/doi.org\/10.1073\/PNAS.0802076105.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2461_CR84","doi-asserted-by":"publisher","unstructured":"Akundi RS, Huang Z, Eason J, Pandya JD, Zhi L, Cass WA, et al. Increased mitochondrial calcium sensitivity and abnormal expression of innate immunity genes precede dopaminergic defects in Pink1-deficient mice. PLoS ONE. 2011;6. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0016038.","DOI":"10.1371\/JOURNAL.PONE.0016038"},{"key":"2461_CR85","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/J.EXPNEUROL.2012.01.002","volume":"235","author":"L Glasl","year":"2012","unstructured":"Glasl L, Kloos K, Giesert F, Roethig A, Di Benedetto B, K\u00fchn R, et al. Pink1-deficiency in mice impairs gait, olfaction and serotonergic innervation of the olfactory bulb. Exp Neurol. 2012;235:214\u201327. https:\/\/doi.org\/10.1016\/J.EXPNEUROL.2012.01.002.","journal-title":"Exp Neurol"},{"key":"2461_CR86","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1001\/JAMANEUROL.2013.172","volume":"70","author":"KM Doherty","year":"2013","unstructured":"Doherty KM, Silveira-Moriyama L, Parkkinen L, Healy DG, Farrell M, Mencacci NE, et al. Parkin disease: A clinicopathologic entity? JAMA Neurol. 2013;70:571\u20139. https:\/\/doi.org\/10.1001\/JAMANEUROL.2013.172.","journal-title":"JAMA Neurol"},{"key":"2461_CR87","doi-asserted-by":"publisher","unstructured":"Huang M, Chen S. DJ-1 in neurodegenerative diseases: pathogenesis and clinical application. Prog Neurobiol. 2021;204. https:\/\/doi.org\/10.1016\/J.PNEUROBIO.2021.102114.","DOI":"10.1016\/J.PNEUROBIO.2021.102114"},{"key":"2461_CR88","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/SJ.EMBOR.7400074","volume":"5","author":"T Taira","year":"2004","unstructured":"Taira T, Saito Y, Niki T, Iguchi-Ariga SMM, Takahashi K, Ariga H. DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep. 2004;5:213\u20138. https:\/\/doi.org\/10.1038\/SJ.EMBOR.7400074.","journal-title":"EMBO Rep"},{"key":"2461_CR89","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41419-019-1679-x","volume":"10","author":"R Chen","year":"2019","unstructured":"Chen R, Park HA, Mnatsakanyan N, Niu Y, Licznerski P, Wu J, et al. Parkinson\u2019s disease protein DJ-1 regulates ATP synthase protein components to increase neuronal process outgrowth. Cell Death Disease 2019. 2019;10:6. https:\/\/doi.org\/10.1038\/s41419-019-1679-x.","journal-title":"Cell Death Disease 2019"},{"key":"2461_CR90","doi-asserted-by":"publisher","unstructured":"Repici M, Giorgini F. DJ-1 in parkinson\u2019s disease: clinical insights and therapeutic perspectives. J Clin Med. 2019;8. https:\/\/doi.org\/10.3390\/JCM8091377.","DOI":"10.3390\/JCM8091377"},{"key":"2461_CR91","doi-asserted-by":"publisher","first-page":"e1884","DOI":"10.1371\/JOURNAL.PONE.0001884","volume":"3","author":"S Batelli","year":"2008","unstructured":"Batelli S, Albani D, Rametta R, Polito L, Prato F, Pesaresi M, et al. DJ-1 modulates \u03b1-Synuclein aggregation state in a cellular model of oxidative stress: relevance for parkinson\u2019s disease and involvement of HSP70. PLoS ONE. 2008;3:e1884. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0001884.","journal-title":"PLoS ONE"},{"key":"2461_CR92","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/BRAIN\/AWAB446","volume":"145","author":"S Smajic","year":"2022","unstructured":"Smajic S, Prada-Medina CA, Landoulsi Z, Ghelfi J, Delcambre S, Dietrich C, et al. Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state. Brain. 2022;145:964\u201378. https:\/\/doi.org\/10.1093\/BRAIN\/AWAB446.","journal-title":"Brain"},{"key":"2461_CR93","doi-asserted-by":"publisher","unstructured":"Lin Z, Chen C, Yang D, Ding J, Wang G, Ren H. DJ-1 inhibits microglial activation and protects dopaminergic neurons in vitro and in vivo through interacting with microglial p65. Cell Death Dis. 2021;12. https:\/\/doi.org\/10.1038\/S41419-021-04002-1.","DOI":"10.1038\/S41419-021-04002-1"},{"key":"2461_CR94","doi-asserted-by":"publisher","unstructured":"Lind-Holm Mogensen F, Scafidi A, Poli A, Michelucci A. PARK7\/DJ-1 in microglia: implications in Parkinson\u2019s disease and relevance as a therapeutic target. Journal of Neuroinflammation 2023 20:1 2023;20:1\u201319. https:\/\/doi.org\/10.1186\/S12974-023-02776-Z","DOI":"10.1186\/S12974-023-02776-Z"},{"key":"2461_CR95","doi-asserted-by":"publisher","first-page":"17296","DOI":"10.1073\/PNAS.1922184117\/SUPPL_FILE\/PNAS.1922184117.SAPP.PDF","volume":"117","author":"APT Nguyen","year":"2020","unstructured":"Nguyen APT, Tsika E, Kelly K, Levine N, Chen X, West AB, et al. Dopaminergic neurodegeneration induced by parkinson\u2019s disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity. Proc Natl Acad Sci U S A. 2020;117:17296\u2013307. https:\/\/doi.org\/10.1073\/PNAS.1922184117\/SUPPL_FILE\/PNAS.1922184117.SAPP.PDF.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2461_CR96","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/S00109-012-0984-Y","volume":"91","author":"PS Guerreiro","year":"2013","unstructured":"Guerreiro PS, Huang Y, Gysbers A, Cheng D, Gai WP, Outeiro TF, et al. LRRK2 interactions with \u03b1-synuclein in parkinson\u2019s disease brains and in cell models. J Mol Med (Berl). 2013;91:513\u201322. https:\/\/doi.org\/10.1007\/S00109-012-0984-Y.","journal-title":"J Mol Med (Berl)"},{"key":"2461_CR97","doi-asserted-by":"publisher","unstructured":"Xiong Y, Neifert S, Karuppagounder SS, Stankowski JN, Lee BD, Grima JC, et al. Overexpression of parkinson\u2019s Disease-Associated mutation LRRK2 G2019S in mouse forebrain induces behavioral deficits and \u03b1-Synuclein pathology. ENeuro. 2017;4. https:\/\/doi.org\/10.1523\/ENEURO.0004-17.2017.","DOI":"10.1523\/ENEURO.0004-17.2017"},{"key":"2461_CR98","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/S40246-019-0203-9","volume":"13","author":"R Spataro","year":"2019","unstructured":"Spataro R, Kousi M, Farhan SMK, Willer JR, Ross JP, Dion PA, et al. Mutations in ATP13A2 (PARK9) are associated with an amyotrophic lateral sclerosis-like phenotype, implicating this locus in further phenotypic expansion. Hum Genomics. 2019;13:19. https:\/\/doi.org\/10.1186\/S40246-019-0203-9.","journal-title":"Hum Genomics"},{"key":"2461_CR99","doi-asserted-by":"publisher","first-page":"15281","DOI":"10.1523\/JNEUROSCI.1629-14.2014","volume":"34","author":"T Tsunemi","year":"2014","unstructured":"Tsunemi T, Hamada K, Krainc D. ATP13A2\/PARK9 regulates secretion of exosomes and \u03b1-synuclein. J Neurosci. 2014;34:15281\u20137. https:\/\/doi.org\/10.1523\/JNEUROSCI.1629-14.2014.","journal-title":"J Neurosci"},{"key":"2461_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/IJMS22052689","volume":"22","author":"J Si","year":"2021","unstructured":"Si J, Van den Haute C, Lobbestael E, Martin S, van Veen S, Vangheluwe P, et al. ATP13A2 regulates cellular \u03b1-Synuclein Multimerization, membrane Association, and externalization. Int J Mol Sci. 2021;22:1\u201320. https:\/\/doi.org\/10.3390\/IJMS22052689.","journal-title":"Int J Mol Sci"},{"key":"2461_CR101","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1093\/HMG\/DDT623","volume":"23","author":"JS Park","year":"2014","unstructured":"Park JS, Koentjoro B, Veivers D, Mackay-Sim A, Sue CM. Parkinson\u2019s disease-associated human ATP13A2 (PARK9) deficiency causes zinc dyshomeostasis and mitochondrial dysfunction. Hum Mol Genet. 2014;23:2802\u201315. https:\/\/doi.org\/10.1093\/HMG\/DDT623.","journal-title":"Hum Mol Genet"},{"key":"2461_CR102","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","volume":"364","author":"MC Chartier-Harlin","year":"2004","unstructured":"Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S, et al. \u03b1-synuclein locus duplication as a cause of Familial parkinson\u2019s disease. Lancet. 2004;364:1167\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(04)17103-1.","journal-title":"Lancet"},{"key":"2461_CR103","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1523\/JNEUROSCI.2507-13.2014","volume":"34","author":"C Guardia-Laguarta","year":"2014","unstructured":"Guardia-Laguarta C, Area-Gomez E, R\u00fcb C, Liu Y, Magran\u00e9 J, Becker D, et al. \u03b1-Synuclein is localized to Mitochondria-Associated ER membranes. J Neurosci. 2014;34:249\u201359. https:\/\/doi.org\/10.1523\/JNEUROSCI.2507-13.2014.","journal-title":"J Neurosci"},{"key":"2461_CR104","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1126\/SCIENCE.1077209","volume":"299","author":"V Bonifati","year":"2003","unstructured":"Bonifati V, Rizzu P, Van Baren MJ, Schaap O, Breedveld GJ, Krieger E, et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science. 2003;299:256\u20139. https:\/\/doi.org\/10.1126\/SCIENCE.1077209.","journal-title":"Science"},{"key":"2461_CR105","doi-asserted-by":"publisher","unstructured":"Ariga H, Takahashi-Niki K, Kato I, Maita H, Niki T, Iguchi-Ariga SMM. Neuroprotective function of DJ-1 in parkinson\u2019s disease. Oxid Med Cell Longev. 2013;2013. https:\/\/doi.org\/10.1155\/2013\/683920.","DOI":"10.1155\/2013\/683920"},{"key":"2461_CR106","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1093\/HMG\/DDU543","volume":"24","author":"DA Beccano-Kelly","year":"2015","unstructured":"Beccano-Kelly DA, Volta M, Lise LN, Paschall SA, Tatarnikov I, Co K, et al. LRRK2 overexpression alters glutamatergic presynaptic plasticity, striatal dopamine tone, postsynaptic signal transduction, motor activity and memory. Hum Mol Genet. 2015;24:1336\u201349. https:\/\/doi.org\/10.1093\/HMG\/DDU543.","journal-title":"Hum Mol Genet"},{"key":"2461_CR107","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1016\/S1353-8020(13)70010-5","volume":"20","author":"S Fujioka","year":"2014","unstructured":"Fujioka S, Ogaki K, Tacik PM, Uitti RJ, Ross OA, Wszolek ZK. Update on novel Familial forms of parkinson\u2019s disease and multiple system atrophy. Parkinsonism Relat Disord. 2014;20:S29\u201334. https:\/\/doi.org\/10.1016\/S1353-8020(13)70010-5.","journal-title":"Parkinsonism Relat Disord"},{"key":"2461_CR108","doi-asserted-by":"publisher","unstructured":"Yuan Y, Cao P, Smith MA, Kramp K, Huang Y, Hisamoto N, et al. Dysregulated LRRK2 signaling in response to Endoplasmic reticulum stress leads to dopaminergic neuron degeneration in C. elegans. PLoS ONE. 2011;6. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0022354.","DOI":"10.1371\/JOURNAL.PONE.0022354"},{"key":"2461_CR109","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/MDS.26243","volume":"30","author":"JS Park","year":"2015","unstructured":"Park JS, Blair NF, Sue CM. The role of ATP13A2 in parkinson\u2019s disease: clinical phenotypes and molecular mechanisms. Mov Disord. 2015;30:770\u20139. https:\/\/doi.org\/10.1002\/MDS.26243.","journal-title":"Mov Disord"},{"key":"2461_CR110","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/J.NBD.2011.12.015","volume":"45","author":"AM Gusdon","year":"2012","unstructured":"Gusdon AM, Zhu J, Van Houten B, Chu CT. ATP13A2 regulates mitochondrial bioenergetics through macroautophagy. Neurobiol Dis. 2012;45:962\u201372. https:\/\/doi.org\/10.1016\/J.NBD.2011.12.015.","journal-title":"Neurobiol Dis"},{"key":"2461_CR111","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/J.AJHG.2011.06.008","volume":"89","author":"A Zimprich","year":"2011","unstructured":"Zimprich A, Benet-Pag\u00e8s A, Struhal W, Graf E, Eck SH, Offman MN, et al. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am J Hum Genet. 2011;89:168\u201375. https:\/\/doi.org\/10.1016\/J.AJHG.2011.06.008.","journal-title":"Am J Hum Genet"},{"key":"2461_CR112","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/J.AJHG.2011.06.001","volume":"89","author":"C Vilari\u00f1o-G\u00fcell","year":"2011","unstructured":"Vilari\u00f1o-G\u00fcell C, Wider C, Ross OA, Dachsel JC, Kachergus JM, Lincoln SJ, et al. VPS35 mutations in Parkinson disease. Am J Hum Genet. 2011;89:162\u20137. https:\/\/doi.org\/10.1016\/J.AJHG.2011.06.001.","journal-title":"Am J Hum Genet"},{"key":"2461_CR113","doi-asserted-by":"publisher","unstructured":"Nagatsu T, Mogi M, Ichinose H, Togari A. Cytokines in parkinson\u2019s disease. J Neural Transmission Supplement. 2000;143\u201351. https:\/\/doi.org\/10.1007\/978-3-7091-6284-2_12.","DOI":"10.1007\/978-3-7091-6284-2_12"},{"key":"2461_CR114","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/ANA.25557","volume":"86","author":"V Grozdanov","year":"2019","unstructured":"Grozdanov V, Bousset L, Hoffmeister M, Bliederhaeuser C, Meier C, Madiona K, et al. Increased immune activation by pathologic \u03b1-Synuclein in parkinson\u2019s disease. Ann Neurol. 2019;86:593\u2013606. https:\/\/doi.org\/10.1002\/ANA.25557.","journal-title":"Ann Neurol"},{"key":"2461_CR115","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/J.NBD.2005.08.002","volume":"21","author":"A Gerhard","year":"2006","unstructured":"Gerhard A, Pavese N, Hotton G, Turkheimer F, Es M, Hammers A, et al. In vivo imaging of microglial activation with [11\u00a0C](R)-PK11195 PET in idiopathic parkinson\u2019s disease. Neurobiol Dis. 2006;21:404\u201312. https:\/\/doi.org\/10.1016\/J.NBD.2005.08.002.","journal-title":"Neurobiol Dis"},{"key":"2461_CR116","doi-asserted-by":"publisher","unstructured":"Wang Q, Liu Y, Zhou J. Neuroinflammation in parkinson\u2019s disease and its potential as therapeutic target. Transl Neurodegener. 2015;4. https:\/\/doi.org\/10.1186\/S40035-015-0042-0.","DOI":"10.1186\/S40035-015-0042-0"},{"key":"2461_CR117","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/S40478-020-01083-5","volume":"8","author":"A Kouli","year":"2020","unstructured":"Kouli A, Camacho M, Allinson K, Williams-Gray CH. Neuroinflammation and protein pathology in parkinson\u2019s disease dementia. Acta Neuropathol Commun. 2020;8:211. https:\/\/doi.org\/10.1186\/S40478-020-01083-5.","journal-title":"Acta Neuropathol Commun"},{"key":"2461_CR118","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/J.NBD.2006.06.013","volume":"24","author":"CC Ferrari","year":"2006","unstructured":"Ferrari CC, Pott Godoy MC, Tarelli R, Chertoff M, Depino AM, Pitossi FJ. Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1beta in the substantia Nigra. Neurobiol Dis. 2006;24:183\u201393. https:\/\/doi.org\/10.1016\/J.NBD.2006.06.013.","journal-title":"Neurobiol Dis"},{"key":"2461_CR119","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1096\/FJ.04-2751COM","volume":"19","author":"W Zhang","year":"2005","unstructured":"Zhang W, Wang T, Pei Z, Miller DS, Wu X, Block ML, et al. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in parkinson\u2019s disease. FASEB J. 2005;19:533\u201342. https:\/\/doi.org\/10.1096\/FJ.04-2751COM.","journal-title":"FASEB J"},{"key":"2461_CR120","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/NATURE22815","volume":"546","author":"D Sulzer","year":"2017","unstructured":"Sulzer D, Alcalay RN, Garretti F, Cote L, Kanter E, Agin-Liebes J, et al. T cells from patients with parkinson\u2019s disease recognize \u03b1-synuclein peptides. Nature. 2017;546:656\u201361. https:\/\/doi.org\/10.1038\/NATURE22815.","journal-title":"Nature"},{"key":"2461_CR121","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1093\/BRAIN\/AWAA269","volume":"143","author":"J Galiano-Landeira","year":"2020","unstructured":"Galiano-Landeira J, Torra A, Vila M, Bov\u00e9 J. CD8 T cell nigral infiltration precedes synucleinopathy in early stages of parkinson\u2019s disease. Brain. 2020;143:3717\u201333. https:\/\/doi.org\/10.1093\/BRAIN\/AWAA269.","journal-title":"Brain"},{"key":"2461_CR122","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1093\/BRAIN\/AWAE177","volume":"147","author":"C Roodveldt","year":"2024","unstructured":"Roodveldt C, Bernardino L, Oztop-Cakmak O, Dragic M, Fladmark KE, Ertan S, et al. The immune system in parkinson\u2019s disease: what we know so Far. Brain. 2024;147:3306. https:\/\/doi.org\/10.1093\/BRAIN\/AWAE177.","journal-title":"Brain"},{"key":"2461_CR123","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1038\/S41593-024-01775-4","volume":"27","author":"A Bayati","year":"2024","unstructured":"Bayati A, Ayoubi R, Aguila A, Zorca CE, Deyab G, Han C, et al. Modeling parkinson\u2019s disease pathology in human dopaminergic neurons by sequential exposure to \u03b1-synuclein fibrils and Proinflammatory cytokines. Nat Neurosci. 2024;27:2401\u201316. https:\/\/doi.org\/10.1038\/S41593-024-01775-4.","journal-title":"Nat Neurosci"},{"key":"2461_CR124","doi-asserted-by":"publisher","unstructured":"Magistrelli L, Contaldi E, Vignaroli F, Gallo S, Colombatto F, Cantello R, et al. Immune response modifications in the genetic forms of parkinson\u2019s disease: what do we know? Int J Mol Sci. 2022;23. https:\/\/doi.org\/10.3390\/IJMS23073476.","DOI":"10.3390\/IJMS23073476"},{"key":"2461_CR125","doi-asserted-by":"crossref","unstructured":"Zheng J, Zhang X, Zhen X. Development of Adenosine A2A Receptor Antagonists for the Treatment of Parkinson\u2019s Disease: A Recent Update and Challenge. ACS Chem Neurosci 2019;10:783\u201391.","DOI":"10.1021\/acschemneuro.8b00313"},{"key":"2461_CR126","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/S007020100004\/METRICS","volume":"108","author":"N Schmidt","year":"2001","unstructured":"Schmidt N, Ferger B. Neurochemical findings in the MPTP model of parkinson\u2019s disease. J Neural Transm. 2001;108:1263\u201382. https:\/\/doi.org\/10.1007\/S007020100004\/METRICS.","journal-title":"J Neural Transm"},{"key":"2461_CR127","doi-asserted-by":"publisher","first-page":"323747","DOI":"10.3389\/FNINS.2018.00090\/BIBTEX","volume":"12","author":"Y Lu","year":"2018","unstructured":"Lu Y, Zhang X, Zhao L, Yang C, Pan L, Li C, et al. Metabolic disturbances in the striatum and substantia Nigra in the onset and progression of MPTP-induced parkinsonism model. Front Neurosci. 2018;12:323747. https:\/\/doi.org\/10.3389\/FNINS.2018.00090\/BIBTEX.","journal-title":"Front Neurosci"},{"key":"2461_CR128","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1002\/MDS.21010","volume":"21","author":"GE Meredith","year":"2006","unstructured":"Meredith GE, Kang UJ. Behavioral models of parkinson\u2019s disease in rodents: A new look at an old problem. Mov Disord. 2006;21:1595\u2013606. https:\/\/doi.org\/10.1002\/MDS.21010.","journal-title":"Mov Disord"},{"key":"2461_CR129","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/BIES.10067","volume":"24","author":"R Betarbet","year":"2002","unstructured":"Betarbet R, Sherer TB, Timothy Greenamyre J. Animal models of parkinson\u2019s disease. BioEssays. 2002;24:308\u201318. https:\/\/doi.org\/10.1002\/BIES.10067.","journal-title":"BioEssays"},{"key":"2461_CR130","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1046\/J.1471-4159.1996.66020658.X","volume":"66","author":"DE Dluzen","year":"1996","unstructured":"Dluzen DE, McDermott JL, Liu B. Estrogen alters MPTP-Induced neurotoxicity in female mice: effects on striatal dopamine concentrations and release. J Neurochem. 1996;66:658\u201366. https:\/\/doi.org\/10.1046\/J.1471-4159.1996.66020658.X.","journal-title":"J Neurochem"},{"key":"2461_CR131","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1007\/S12035-015-9179-1\/SCHEMES\/1","volume":"53","author":"A Kumar","year":"2016","unstructured":"Kumar A, Leinisch F, Kadiiska MB, Corbett J, Mason RP. Formation and implications of Alpha-Synuclein radical in Maneb- and Paraquat-Induced models of parkinson\u2019s disease. Mol Neurobiol. 2016;53:2983\u201394. https:\/\/doi.org\/10.1007\/S12035-015-9179-1\/SCHEMES\/1.","journal-title":"Mol Neurobiol"},{"key":"2461_CR132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2202-15-21\/FIGURES\/5","volume":"15","author":"K Muthukumaran","year":"2014","unstructured":"Muthukumaran K, Leahy S, Harrison K, Sikorska M, Sandhu JK, Cohen J, et al. Orally delivered water soluble coenzyme Q10 (Ubisol-Q10) blocks on-going neurodegeneration in rats exposed to paraquat: potential for therapeutic application in parkinson\u2019s disease. BMC Neurosci. 2014;15:1\u201311. https:\/\/doi.org\/10.1186\/1471-2202-15-21\/FIGURES\/5.","journal-title":"BMC Neurosci"},{"key":"2461_CR133","doi-asserted-by":"publisher","first-page":"762","DOI":"10.4103\/1673-5374.249847","volume":"14","author":"M Bisbal","year":"2019","unstructured":"Bisbal M, Sanchez M. Neurotoxicity of the pesticide rotenone on neuronal polarization: A mechanistic approach. Neural Regen Res. 2019;14:762\u20136. https:\/\/doi.org\/10.4103\/1673-5374.249847.","journal-title":"Neural Regen Res"},{"key":"2461_CR134","doi-asserted-by":"publisher","unstructured":"Terron A, Bal-Price A, Paini A, Monnet-Tschudi F, Bennekou SH, Angeli K et al. An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I Inhibition. Archives Toxicol 2017 92:1 2017;92:41\u201382. https:\/\/doi.org\/10.1007\/S00204-017-2133-4","DOI":"10.1007\/S00204-017-2133-4"},{"key":"2461_CR135","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/J.NBD.2009.01.016","volume":"34","author":"JR Cannon","year":"2009","unstructured":"Cannon JR, Tapias V, Na HM, Honick AS, Drolet RE, Greenamyre JT. A highly reproducible rotenone model of parkinson\u2019s disease. Neurobiol Dis. 2009;34:279\u201390. https:\/\/doi.org\/10.1016\/J.NBD.2009.01.016.","journal-title":"Neurobiol Dis"},{"key":"2461_CR136","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/BRAIN\/AWW230","volume":"140","author":"M Goedert","year":"2017","unstructured":"Goedert M, Masuda-Suzukake M, Falcon B. Like prions: the propagation of aggregated Tau and \u03b1-synuclein in neurodegeneration. Brain. 2017;140:266\u201378. https:\/\/doi.org\/10.1093\/BRAIN\/AWW230.","journal-title":"Brain"},{"key":"2461_CR137","doi-asserted-by":"publisher","first-page":"123773","DOI":"10.3389\/FNANA.2014.00159\/REFERENCE","volume":"8","author":"A Recasens","year":"2014","unstructured":"Recasens A, Dehay B. Alpha-synuclein spreading in parkinson\u2019s disease. Front Neuroanat. 2014;8:123773. https:\/\/doi.org\/10.3389\/FNANA.2014.00159\/REFERENCE.","journal-title":"Front Neuroanat"},{"key":"2461_CR138","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1007\/S13311-014-0284-Z","volume":"11","author":"IN Rudenko","year":"2014","unstructured":"Rudenko IN, Cookson MR. Heterogeneity of Leucine-Rich repeat kinase 2 mutations: Genetics, mechanisms and therapeutic implications. Neurotherapeutics. 2014;11:738\u201350. https:\/\/doi.org\/10.1007\/S13311-014-0284-Z.","journal-title":"Neurotherapeutics"},{"key":"2461_CR139","doi-asserted-by":"publisher","first-page":"164","DOI":"10.4161\/SGTP.25130","volume":"4","author":"E Tsika","year":"2013","unstructured":"Tsika E, Moore DJ. Contribution of GTPase activity to LRRK2-associated Parkinson disease. Small GTPases. 2013;4:164\u201370. https:\/\/doi.org\/10.4161\/SGTP.25130.","journal-title":"Small GTPases"},{"key":"2461_CR140","doi-asserted-by":"publisher","first-page":"844534","DOI":"10.3389\/FNAGI.2022.844534\/BIBTEX","volume":"14","author":"C Luchena","year":"2022","unstructured":"Luchena C, Zuazo-Ibarra J, Valero J, Matute C, Alberdi E, Capetillo-Zarate E. A Neuron, Microglia, and astrocyte triple Co-culture model to study alzheimer\u2019s disease. Front Aging Neurosci. 2022;14:844534. https:\/\/doi.org\/10.3389\/FNAGI.2022.844534\/BIBTEX.","journal-title":"Front Aging Neurosci"},{"key":"2461_CR141","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/J.BBRC.2023.03.068","volume":"658","author":"L Xiao","year":"2023","unstructured":"Xiao L, Mochizuki M, Wang D, Shimamura N, Sunada K, Nakahara T. Types of cell culture inserts affect cell crosstalk between co-cultured macrophages and adipocytes. Biochem Biophys Res Commun. 2023;658:10\u20137. https:\/\/doi.org\/10.1016\/J.BBRC.2023.03.068.","journal-title":"Biochem Biophys Res Commun"},{"key":"2461_CR142","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/CNS.12825","volume":"24","author":"XX Chen","year":"2018","unstructured":"Chen XX, Qian Y, Wang XP, Tang ZW, Xu JT, Lin H, et al. Nurr1 promotes neurogenesis of dopaminergic neuron and represses inflammatory factors in the transwell coculture system of neural stem cells and microglia. CNS Neurosci Ther. 2018;24:790. https:\/\/doi.org\/10.1111\/CNS.12825.","journal-title":"CNS Neurosci Ther"},{"key":"2461_CR143","doi-asserted-by":"publisher","first-page":"9707","DOI":"10.2147\/IJN.S225451","volume":"14","author":"L Chen","year":"2019","unstructured":"Chen L, Wu M, Jiang S, Zhang Y, Li R, Lu Y, et al. Skin toxicity assessment of silver nanoparticles in a 3D epidermal model compared to 2D keratinocytes. Int J Nanomed. 2019;14:9707. https:\/\/doi.org\/10.2147\/IJN.S225451.","journal-title":"Int J Nanomed"},{"key":"2461_CR144","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/BCR2800\/METRICS","volume":"13","author":"SK Muthuswamy","year":"2011","unstructured":"Muthuswamy SK. 3D culture reveals a signaling network. Breast Cancer Res. 2011;13:1\u20132. https:\/\/doi.org\/10.1186\/BCR2800\/METRICS.","journal-title":"Breast Cancer Res"},{"key":"2461_CR145","doi-asserted-by":"publisher","first-page":"117327","DOI":"10.1016\/J.ECOENV.2024.117327","volume":"288","author":"V Holgersson","year":"2024","unstructured":"Holgersson V, Joyce S, Brookman-Amissah M, Lammel T. Comparative analysis of 3D and 2D in vitro models of the permanent fish liver cell line RTL-W1: metabolic capabilities and responses to xenobiotics. Ecotoxicol Environ Saf. 2024;288:117327. https:\/\/doi.org\/10.1016\/J.ECOENV.2024.117327.","journal-title":"Ecotoxicol Environ Saf"},{"key":"2461_CR146","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/J.STEM.2023.05.015","volume":"30","author":"MS Kim","year":"2023","unstructured":"Kim MS, Ra EA, Kweon SH, Seo BA, Ko HS, Oh Y, et al. Advanced human iPSC-based preclinical model for parkinson\u2019s disease with optogenetic alpha-synuclein aggregation. Cell Stem Cell. 2023;30:973. https:\/\/doi.org\/10.1016\/J.STEM.2023.05.015.","journal-title":"Cell Stem Cell"},{"key":"2461_CR147","doi-asserted-by":"publisher","unstructured":"Urz\u00ec O, Gasparro R, Costanzo E, De Luca A, Giavaresi G, Fontana S, et al. Three-Dimensional cell cultures: the Bridge between in vitro and in vivo models. Int J Mol Sci 2023. Page 12046 2023;24:24:12046. https:\/\/doi.org\/10.3390\/IJMS241512046.","DOI":"10.3390\/IJMS241512046"},{"key":"2461_CR148","doi-asserted-by":"publisher","unstructured":"Samimi H, Sohi AN, Irani S, Arefian E, Mahdiannasser M, Fallah P, et al. Alginate-based 3D cell culture technique to evaluate the half-maximal inhibitory concentration: an in vitro model of anticancer drug study for anaplastic thyroid carcinoma. Thyroid Res. 2021;14. https:\/\/doi.org\/10.1186\/S13044-021-00118-W.","DOI":"10.1186\/S13044-021-00118-W"},{"key":"2461_CR149","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1517\/14712598.2012.707181","volume":"12","author":"TM Achilli","year":"2012","unstructured":"Achilli TM, Meyer J, Morgan JR. Advances in the formation, use and Understanding of multi-cellular spheroids. Expert Opin Biol Ther. 2012;12:1347\u201360. https:\/\/doi.org\/10.1517\/14712598.2012.707181.","journal-title":"Expert Opin Biol Ther"},{"key":"2461_CR150","doi-asserted-by":"publisher","unstructured":"Ryu NE, Lee SH, Park H. Spheroid culture system methods and applications for mesenchymal stem cells. Cells 2019;8. https:\/\/doi.org\/10.3390\/CELLS8121620","DOI":"10.3390\/CELLS8121620"},{"key":"2461_CR151","doi-asserted-by":"publisher","unstructured":"Razian G, Yu Y, Ungrin M. Production of large numbers of Size-controlled tumor spheroids using microwell plates. J Vis Exp. 2013;50665. https:\/\/doi.org\/10.3791\/50665.","DOI":"10.3791\/50665"},{"key":"2461_CR152","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/J.JCYT.2021.02.035","volume":"23","author":"V Queiroz","year":"2021","unstructured":"Queiroz V, Sales S, Nicoliche T, Erustes A, Pereira G, Smaili S, DEVELOPMENT OF SCAFFOLD-FREE SPHEROIDS OVEREXPRESSING ALPHA-SYNUCLEIN IN HUMAN NEUROBLASTOMA SH-SY5Y AS A MODEL OF PARKINSON\u2019S DISEASE, et al. Cytotherapy. 2021;23:10\u20131. https:\/\/doi.org\/10.1016\/J.JCYT.2021.02.035.","journal-title":"Cytotherapy"},{"key":"2461_CR153","doi-asserted-by":"publisher","unstructured":"Strong CE, Zhang J, Carrasco M, Kundu S, Boutin M, Vishwasrao HD et al. Functional brain region-specific neural spheroids for modeling neurological diseases and therapeutics screening. Communications Biology. 2023 6:1 2023;6:1\u201318. https:\/\/doi.org\/10.1038\/s42003-023-05582-8","DOI":"10.1038\/s42003-023-05582-8"},{"key":"2461_CR154","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/S00441-005-0148-2\/FIGURES\/8","volume":"324","author":"RZ Lin","year":"2006","unstructured":"Lin RZ, Chou LF, Chien CCM, Chang HY. Dynamic analysis of hepatoma spheroid formation: roles of E-cadherin and \u03b21-integrin. Cell Tissue Res. 2006;324:411\u201322. https:\/\/doi.org\/10.1007\/S00441-005-0148-2\/FIGURES\/8.","journal-title":"Cell Tissue Res"},{"key":"2461_CR155","doi-asserted-by":"publisher","unstructured":"Hendriks D, Artegiani B, Hu H, Chuva de Sousa Lopes S, Clevers H. Establishment of human fetal hepatocyte organoids and CRISPR\u2013Cas9-based gene knockin and knockout in organoid cultures from human liver. Nat Protocols 2020 16:1 2020;16:182\u2013217. https:\/\/doi.org\/10.1038\/s41596-020-00411-2","DOI":"10.1038\/s41596-020-00411-2"},{"key":"2461_CR156","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1083\/JCB.201610056","volume":"216","author":"M Simian","year":"2017","unstructured":"Simian M, Bissell MJ, Organoids. A historical perspective of thinking in three dimensions. J Cell Biol. 2017;216:31\u201340. https:\/\/doi.org\/10.1083\/JCB.201610056.","journal-title":"J Cell Biol"},{"key":"2461_CR157","doi-asserted-by":"publisher","first-page":"16978","DOI":"10.1073\/PNAS.0905550106","volume":"106","author":"YS Hwang","year":"2009","unstructured":"Hwang YS, Bong GC, Ortmann D, Hattori N, Moeller HC, Khademhosseinia A. Microwell-mediated control of embryoid body size regulates embryonic stem cell fate via differential expression of WNT5a and WNT11. Proc Natl Acad Sci U S A. 2009;106:16978. https:\/\/doi.org\/10.1073\/PNAS.0905550106.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2461_CR158","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.stemcr.2019.01.020","volume":"12","author":"H Kim","year":"2019","unstructured":"Kim H, Park HJ, Choi H, Chang Y, Park H, Shin J, et al. Modeling G2019S-LRRK2 sporadic parkinson\u2019s disease in 3D midbrain organoids. Stem Cell Rep. 2019;12:518\u201331. https:\/\/doi.org\/10.1016\/j.stemcr.2019.01.020.","journal-title":"Stem Cell Rep"},{"key":"2461_CR159","doi-asserted-by":"publisher","unstructured":"Maji S, Lee H. Engineering hydrogels for the development of Three-Dimensional in vitro models. Int J Mol Sci. 2022;23. https:\/\/doi.org\/10.3390\/IJMS23052662.","DOI":"10.3390\/IJMS23052662"},{"key":"2461_CR160","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/BIT.22361","volume":"103","author":"MW Tibbitt","year":"2009","unstructured":"Tibbitt MW, Anseth KS. Hydrogels as extracellular matrix mimics for 3D cell culture. Biotechnol Bioeng. 2009;103:655. https:\/\/doi.org\/10.1002\/BIT.22361.","journal-title":"Biotechnol Bioeng"},{"key":"2461_CR161","doi-asserted-by":"publisher","unstructured":"Gilmozzi V, Gentile G, Riekschnitz DA, Von Troyer M, Lavdas AA, Kerschbamer E, et al. Generation of hiPSC-Derived functional dopaminergic neurons in Alginate-Based 3D culture. Front Cell Dev Biol. 2021;9. https:\/\/doi.org\/10.3389\/FCELL.2021.708389\/FULL.","DOI":"10.3389\/FCELL.2021.708389\/FULL"},{"key":"2461_CR162","doi-asserted-by":"publisher","unstructured":"Li ZF, Cui L, Jin MM, Hu DY, Hou XG, Liu SS, et al. A Matrigel-based 3D construct of SH-SY5Y cells models the \u03b1-synuclein pathologies of parkinson\u2019s disease. DMM Disease Models Mech. 2022;15. https:\/\/doi.org\/10.1242\/DMM.049125\/273997\/AM\/A-MATRIGEL-BASED-3D-CONSTRUCT-OF-SH-SY5Y-CELLS.","DOI":"10.1242\/DMM.049125\/273997\/AM\/A-MATRIGEL-BASED-3D-CONSTRUCT-OF-SH-SY5Y-CELLS"},{"key":"2461_CR163","doi-asserted-by":"publisher","unstructured":"Abdelrahman S, Alsanie WF, Khan ZN, Albalawi HI, Felimban RI, Moretti M et al. A parkinson\u2019s disease model composed of 3D bioprinted dopaminergic neurons within a biomimetic peptide scaffold. Biofabrication 2022;14. https:\/\/doi.org\/10.1088\/1758-5090\/AC7EEC","DOI":"10.1088\/1758-5090\/AC7EEC"},{"key":"2461_CR164","doi-asserted-by":"publisher","first-page":"112131","DOI":"10.1016\/J.MSEC.2021.112131","volume":"126","author":"S Shahidi","year":"2021","unstructured":"Shahidi S, Janmaleki M, Riaz S, Sanati Nezhad A, Syed N. A tuned gelatin methacryloyl (GelMA) hydrogel facilitates myelination of dorsal root ganglia neurons in vitro. Mater Sci Engineering: C. 2021;126:112131. https:\/\/doi.org\/10.1016\/J.MSEC.2021.112131.","journal-title":"Mater Sci Engineering: C"},{"key":"2461_CR165","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/J.MSEC.2017.03.264","volume":"77","author":"P Sensharma","year":"2017","unstructured":"Sensharma P, Madhumathi G, Jayant RD, Jaiswal AK. Biomaterials and cells for neural tissue engineering: current choices. Mater Sci Engineering: C. 2017;77:1302\u201315. https:\/\/doi.org\/10.1016\/J.MSEC.2017.03.264.","journal-title":"Mater Sci Engineering: C"},{"key":"2461_CR166","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/S12195-018-0530-2\/FIGURES\/6","volume":"11","author":"N Tasnim","year":"2018","unstructured":"Tasnim N, De la Vega L, Anil Kumar S, Abelseth L, Alonzo M, Amereh M, et al. 3D Bioprinting stem cell derived tissues. Cell Mol Bioeng. 2018;11:219\u201340. https:\/\/doi.org\/10.1007\/S12195-018-0530-2\/FIGURES\/6.","journal-title":"Cell Mol Bioeng"},{"key":"2461_CR167","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/S13206-018-3101-7\/FIGURES\/4","volume":"13","author":"HN Kim","year":"2019","unstructured":"Kim HN, Choi N. Consideration of the mechanical properties of hydrogels for brain tissue engineering and brain-on-a-chip. Biochip J. 2019;13:8\u201319. https:\/\/doi.org\/10.1007\/S13206-018-3101-7\/FIGURES\/4.","journal-title":"Biochip J"},{"key":"2461_CR168","doi-asserted-by":"publisher","first-page":"015001","DOI":"10.1088\/1758-5082\/6\/1\/015001","volume":"6","author":"B Lorber","year":"2013","unstructured":"Lorber B, Hsiao WK, Hutchings IM, Martin KR. Adult rat retinal ganglion cells and glia can be printed by piezoelectric inkjet printing. Biofabrication. 2013;6:015001. https:\/\/doi.org\/10.1088\/1758-5082\/6\/1\/015001.","journal-title":"Biofabrication"},{"key":"2461_CR169","doi-asserted-by":"publisher","unstructured":"Fantini V, Bordoni M, Scocozza F, Conti M, Scarian E, Carelli S et al. Bioink composition and printing parameters for 3D modeling neural tissue. Cells 2019;8. https:\/\/doi.org\/10.3390\/cells8080830","DOI":"10.3390\/cells8080830"},{"key":"2461_CR170","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/J.NBD.2017.04.011","volume":"103","author":"F Cavaliere","year":"2017","unstructured":"Cavaliere F, Cerf L, Dehay B, Ramos-Gonzalez P, De Giorgi F, Bourdenx M, et al. In vitro \u03b1-synuclein neurotoxicity and spreading among neurons and astrocytes using lewy body extracts from Parkinson disease brains. Neurobiol Dis. 2017;103:101\u201312. https:\/\/doi.org\/10.1016\/J.NBD.2017.04.011.","journal-title":"Neurobiol Dis"},{"key":"2461_CR171","unstructured":"De Vos D. Suspended extrusion-based Bioprinting to Establish a 3D in vitro model of a neural network to study parkinson\u2019. s disease Major Research Project Report; 2022."},{"key":"2461_CR172","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41531-019-0078-4","volume":"5","author":"LM Smits","year":"2019","unstructured":"Smits LM, Reinhardt L, Reinhardt P, Glatza M, Monzel AS, Stanslowsky N, et al. Modeling parkinson\u2019s disease in midbrain-like organoids. Npj Parkinson\u2019s Disease 2019 5:1. 2019;5:1\u20138. https:\/\/doi.org\/10.1038\/s41531-019-0078-4.","journal-title":"Npj Parkinson\u2019s Disease 2019 5:1"},{"key":"2461_CR173","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3389\/FNINS.2016.00511\/FULL","volume":"10","author":"JTS Fernandes","year":"2016","unstructured":"Fernandes JTS, Chutna O, Chu V, Conde JP, Outeiro TF. A novel microfluidic cell co-culture platform for the study of the molecular mechanisms of parkinson\u2019s disease and other synucleinopathies. Front Neurosci. 2016;10:511. https:\/\/doi.org\/10.3389\/FNINS.2016.00511\/FULL.","journal-title":"Front Neurosci"},{"key":"2461_CR174","doi-asserted-by":"publisher","first-page":"045016","DOI":"10.1088\/2057-1976\/AB2307","volume":"5","author":"M Kamudzandu","year":"2019","unstructured":"Kamudzandu M, K\u00f6se-Dunn M, Evans MG, Fricker RA, Roach P. A micro-fabricated in vitro complex neuronal circuit platform. Biomed Phys Eng Express. 2019;5:045016. https:\/\/doi.org\/10.1088\/2057-1976\/AB2307.","journal-title":"Biomed Phys Eng Express"},{"key":"2461_CR175","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1002\/JBM.A.35689","volume":"104","author":"Z Hesari","year":"2016","unstructured":"Hesari Z, Soleimani M, Atyabi F, Sharifdini M, Nadri S, Warkiani ME, et al. A hybrid microfluidic system for regulation of neural differentiation in induced pluripotent stem cells. J Biomed Mater Res A. 2016;104:1534\u201343. https:\/\/doi.org\/10.1002\/JBM.A.35689.","journal-title":"J Biomed Mater Res A"},{"key":"2461_CR176","doi-asserted-by":"publisher","first-page":"67","DOI":"10.24840\/2183-6493_001.001_0007","volume":"1","author":"RO Rodrigues","year":"2015","unstructured":"Rodrigues RO, Lima R, Gomes HT, Silva AMT. Polymer microfluidic devices: an overview of fabrication methods. UPorto J Eng. 2015;1:67\u201379. https:\/\/doi.org\/10.24840\/2183-6493_001.001_0007.","journal-title":"UPorto J Eng"},{"key":"2461_CR177","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1039\/C9LC00078J","volume":"19","author":"PM Holloway","year":"2019","unstructured":"Holloway PM, Hallinan GI, Hegde M, Lane SIR, Deinhardt K, West J. Asymmetric confinement for defining outgrowth directionality. Lab Chip. 2019;19:1484\u20139. https:\/\/doi.org\/10.1039\/C9LC00078J.","journal-title":"Lab Chip"},{"key":"2461_CR178","doi-asserted-by":"publisher","unstructured":"Maisonneuve BGC, Batut A, Varela C, Vieira J, Gleyzes M, Rontard J et al. Neurite growth kinetics regulation through hydrostatic pressure in a novel triangle-shaped neurofluidic system. BioRxiv 2021:2021.03.23.436675. https:\/\/doi.org\/10.1101\/2021.03.23.436675","DOI":"10.1101\/2021.03.23.436675"},{"key":"2461_CR179","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/S12017-012-8170-5\/FIGURES\/3","volume":"14","author":"IH Yang","year":"2012","unstructured":"Yang IH, Gary D, Malone M, Dria S, Houdayer T, Belegu V, et al. Axon myelination and electrical stimulation in a microfluidic, compartmentalized cell culture platform. Neuromolecular Med. 2012;14:112\u20138. https:\/\/doi.org\/10.1007\/S12017-012-8170-5\/FIGURES\/3.","journal-title":"Neuromolecular Med"},{"key":"2461_CR180","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s43586-022-00118-6","volume":"2","author":"CM Leung","year":"2022","unstructured":"Leung CM, de Haan P, Ronaldson-Bouchard K, Kim GA, Ko J, Rho HS, et al. A guide to the organ-on-a-chip. Nat Reviews Methods Primers 2022. 2022;2:1. https:\/\/doi.org\/10.1038\/s43586-022-00118-6.","journal-title":"Nat Reviews Methods Primers 2022"},{"key":"2461_CR181","doi-asserted-by":"publisher","first-page":"14227","DOI":"10.3390\/IJMS241814227\/S1","volume":"24","author":"MG Otero","year":"2023","unstructured":"Otero MG, Bell S, Laperle AH, Lawless G, Myers Z, Castro MA, et al. Organ-Chips enhance the maturation of human iPSC-Derived dopamine neurons. Int J Mol Sci. 2023;24:14227. https:\/\/doi.org\/10.3390\/IJMS241814227\/S1.","journal-title":"Int J Mol Sci"},{"key":"2461_CR182","doi-asserted-by":"publisher","first-page":"514907","DOI":"10.3389\/FBIOE.2020.00322\/BIBTEX","volume":"8","author":"KV Kitaeva","year":"2020","unstructured":"Kitaeva KV, Rutland CS, Rizvanov AA, Solovyeva VV. Cell culture based in vitro test systems for anticancer drug screening. Front Bioeng Biotechnol. 2020;8:514907. https:\/\/doi.org\/10.3389\/FBIOE.2020.00322\/BIBTEX.","journal-title":"Front Bioeng Biotechnol"},{"key":"2461_CR183","doi-asserted-by":"publisher","first-page":"1800927","DOI":"10.1002\/ADVS.201800927","volume":"6","author":"S Bolognin","year":"2019","unstructured":"Bolognin S, Foss\u00e9pr\u00e9 M, Qing X, Jarazo J, \u0160\u010dan\u010dar J, Moreno EL, et al. 3D cultures of parkinson\u2019s Disease-Specific dopaminergic neurons for high content phenotyping and drug testing. Adv Sci. 2019;6:1800927. https:\/\/doi.org\/10.1002\/ADVS.201800927.","journal-title":"Adv Sci"},{"key":"2461_CR184","doi-asserted-by":"publisher","unstructured":"Strong CE, Kundu S, Boutin M, Chen Y-C, Wilson K, Lee E et al. Functional brain region-specific neural spheroids for modeling neurological diseases and therapeutics screening. BioRxiv 2022:2022.05.04.490442. https:\/\/doi.org\/10.1101\/2022.05.04.490442","DOI":"10.1101\/2022.05.04.490442"},{"key":"2461_CR185","doi-asserted-by":"publisher","unstructured":"Fernandes HJR, Patikas N, Foskolou S, Field SF, Park JE, Byrne ML, et al. Single-Cell transcriptomics of parkinson\u2019s disease human in vitro models reveals dopamine Neuron-Specific stress responses. Cell Rep. 2020;33. https:\/\/doi.org\/10.1016\/J.CELREP.2020.108263\/ATTACHMENT\/FCF4D88D-5420-490A-A8A6-2452418C6AB1\/MMC9.PDF.","DOI":"10.1016\/J.CELREP.2020.108263\/ATTACHMENT\/FCF4D88D-5420-490A-A8A6-2452418C6AB1\/MMC9.PDF"},{"key":"2461_CR186","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/WNR.0000000000001014","volume":"29","author":"MT Pham","year":"2018","unstructured":"Pham MT, Pollock KM, Rose MD, Cary WA, Stewart HR, Zhou P, et al. Generation of human vascularized brain organoids. NeuroReport. 2018;29:588\u201393. https:\/\/doi.org\/10.1097\/WNR.0000000000001014.","journal-title":"NeuroReport"},{"key":"2461_CR187","doi-asserted-by":"publisher","unstructured":"Hofer M, Lutolf MP. Engineering organoids. Nature Reviews Materials. 2021 6:5 2021;6:402\u201320. https:\/\/doi.org\/10.1038\/s41578-021-00279-y","DOI":"10.1038\/s41578-021-00279-y"},{"key":"2461_CR188","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nm.4214","volume":"22","author":"G Quadrato","year":"2016","unstructured":"Quadrato G, Brown J, Arlotta P. The promises and challenges of human brain organoids as models of neuropsychiatric disease. Nat Med 2016. 2016;22:11. https:\/\/doi.org\/10.1038\/nm.4214.","journal-title":"Nat Med 2016"},{"key":"2461_CR189","doi-asserted-by":"publisher","first-page":"7793","DOI":"10.1038\/s41586-020-1962-0","volume":"578","author":"A Bhaduri","year":"2020","unstructured":"Bhaduri A, Andrews MG, Mancia Leon W, Jung D, Shin D, Allen D, et al. Cell stress in cortical organoids impairs molecular subtype specification. Nat 2020. 2020;578:7793. https:\/\/doi.org\/10.1038\/s41586-020-1962-0.","journal-title":"Nat 2020"},{"key":"2461_CR190","doi-asserted-by":"publisher","first-page":"594090","DOI":"10.3389\/FCELL.2020.594090\/BIBTEX","volume":"8","author":"J Ha","year":"2020","unstructured":"Ha J, Kang JS, Lee M, Baek A, Kim S, Chung SK, et al. Simplified brain organoids for rapid and robust modeling of brain disease. Front Cell Dev Biol. 2020;8:594090. https:\/\/doi.org\/10.3389\/FCELL.2020.594090\/BIBTEX.","journal-title":"Front Cell Dev Biol"},{"key":"2461_CR191","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1093\/JMCB\/MJAA036","volume":"12","author":"Y Du","year":"2020","unstructured":"Du Y, Li X, Niu Q, Mo X, Qui M, Ma T, et al. Development of a miniaturized 3D organoid culture platform for ultra-high-throughput screening. J Mol Cell Biol. 2020;12:630. https:\/\/doi.org\/10.1093\/JMCB\/MJAA036.","journal-title":"J Mol Cell Biol"},{"key":"2461_CR192","doi-asserted-by":"publisher","unstructured":"Hofer M, Lutolf MP. Engineering organoids. Nature Reviews Materials 2021 6:5 2021;6:402\u201320. https:\/\/doi.org\/10.1038\/s41578-021-00279-y.","DOI":"10.1038\/s41578-021-00279-y."},{"key":"2461_CR193","doi-asserted-by":"publisher","first-page":"e76373","DOI":"10.1371\/JOURNAL.PONE.0076373","volume":"8","author":"KE Sung","year":"2013","unstructured":"Sung KE, Su X, Berthier E, Pehlke C, Friedl A, Beebe DJ. Understanding the impact of 2D and 3D fibroblast cultures on in vitro breast cancer models. PLoS ONE. 2013;8:e76373. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0076373.","journal-title":"PLoS ONE"},{"key":"2461_CR194","doi-asserted-by":"publisher","unstructured":"Fontoura JC, Viezzer C, dos Santos FG, Ligabue RA, Weinlich R, Puga RD, et al. Comparison of 2D and 3D cell culture models for cell growth, gene expression and drug resistance. Mater Sci Eng C Mater Biol Appl. 2020;107. https:\/\/doi.org\/10.1016\/J.MSEC.2019.110264.","DOI":"10.1016\/J.MSEC.2019.110264"},{"key":"2461_CR195","doi-asserted-by":"publisher","unstructured":"Xu R, Boreland AJ, Li X, Erickson C, Jin M, Atkins C et al. Developing human pluripotent stem cell-based cerebral organoids with a controllable microglia ratio for modeling brain development and pathology. Stem Cell Rep 2021;16:1923. https:\/\/doi.org\/10.1016\/J.STEMCR.2021.06.011","DOI":"10.1016\/J.STEMCR.2021.06.011"},{"key":"2461_CR196","doi-asserted-by":"publisher","unstructured":"Quintard C, Tubbs E, Jonsson G, Jiao J, Wang J, Werschler N et al. A microfluidic platform integrating functional vascularized organoids-on-chip. Nat Commun 2024;15. https:\/\/doi.org\/10.1038\/S41467-024-45710-4","DOI":"10.1038\/S41467-024-45710-4"},{"key":"2461_CR197","doi-asserted-by":"publisher","first-page":"e3002141","DOI":"10.1371\/JOURNAL.PBIO.3002141","volume":"21","author":"B Ye","year":"2023","unstructured":"Ye B. Approaches to vascularizing human brain organoids. PLoS Biol. 2023;21:e3002141. https:\/\/doi.org\/10.1371\/JOURNAL.PBIO.3002141.","journal-title":"PLoS Biol"},{"key":"2461_CR198","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1159\/000529431","volume":"212","author":"S Yip","year":"2023","unstructured":"Yip S, Wang N, Sugimura R. Give them vasculature and immune cells: how to fill the gap of organoids. Cells Tissues Organs. 2023;212:369. https:\/\/doi.org\/10.1159\/000529431.","journal-title":"Cells Tissues Organs"},{"key":"2461_CR199","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1039\/D0LC01186J","volume":"21","author":"S Zhang","year":"2021","unstructured":"Zhang S, Wan Z, Kamm RD. Vascularized organoids on a chip: strategies for engineering organoids with functional vasculature. Lab Chip. 2021;21:473\u201388. https:\/\/doi.org\/10.1039\/D0LC01186J.","journal-title":"Lab Chip"},{"key":"2461_CR200","doi-asserted-by":"publisher","first-page":"692","DOI":"10.3389\/FBIOE.2020.00692","volume":"8","author":"S Gopal","year":"2020","unstructured":"Gopal S, Rodrigues AL, Dordick JS, Exploiting CRISPR. Cas9 in Three-Dimensional stem cell cultures to model disease. Front Bioeng Biotechnol. 2020;8:692. https:\/\/doi.org\/10.3389\/FBIOE.2020.00692.","journal-title":"Front Bioeng Biotechnol"},{"key":"2461_CR201","doi-asserted-by":"publisher","unstructured":"Kang S-Y, Kimura M, Shrestha S, Lewis P, Lee S, Cai Y et al. A pillar and perfusion plate platform for robust human organoid culture and Analysis. BioRxiv 2023:2023.03.11.532210. https:\/\/doi.org\/10.1101\/2023.03.11.532210","DOI":"10.1101\/2023.03.11.532210"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02461-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02461-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02461-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T08:34:44Z","timestamp":1765442084000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-025-02461-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":201,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2461"],"URL":"https:\/\/doi.org\/10.1186\/s12964-025-02461-z","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"526"}}